National Clinical Trials Network (NCTN) Steering Committees
National Clinical Trials Network (NCTN) steering committees are committed to increasing the exchange of information at an early stage of clinical trial development and the efficiency of clinical trial collaboration.
NCTN clinical trial concepts should be submitted to the Cancer Therapy Evaluation Program (CTEP) PIO. Before submitting a clinical trial concept, please refer to the NCTN Steering Committee Concept Submission Guidelines.
- Evaluate and prioritize clinical trial concepts to be conducted through the National Clinical Trials Network (NCTN) or NCI Clinical Oncology Program (NCORP) at monthly meetings. Share information at an early stage of trial development
- Review and update strategic priorities for a given disease or research area and review accrual to ongoing trials approximately annually
- Assess the strength of the clinical trial portfolio and its alignment with the strategic priorities
- Convene clinical trial planning meetings to plan trials and address other trial-related issues as needed
- Form task forces or working groups when needed to focus on a specific disease or issue
NCTN steering committees are made up of the following representatives:
- NCTN group disease committees representatives
- NCORP representatives
- Community oncologists
- Specialized Programs of Research Excellence (SPORE) representatives
- Consortia representatives (if NCI –funded Consortium in disease area)
- Patient advocates
- Up to four Special Clinician/other Experts as needed
- NCI staff
The NCTN enterprise, consisting of the NCTN Groups, Scientific Steering Committees (SSCs), and the NCI, have set disease-specific strategic priorities. These priorities should be used to inform concept submissions, so the two are well aligned.
Rosters for each disease-specific SC, as well individual strategic priorities, can be found on each of the NCTN Disease-Specific Steering Committee pages: